Abstract:Background and Aims. Midkine (MDK) is a heparin-binding growth factor and is over expressed in various types of human cancer. However, little is known about the clinical significance of MDK in non-small cell lung cancer (NSCLC). The aim of this study was to measure MDK protein levels in patients with NSCLC and to explore its clinical significance.Methods. The expression status of MDK in NSCLC at Gene Expression Omnibus (GEO accession number: GSE19804) was observed. The expression of MDK mRNA and protein was examined in NSCLC tissues and normal lung tissues through real-time PCR and Western blot. Meanwhile, the relationship of MDK protein expression levels with clinical characteristics of 186 NSCLC patients was analyzed by immunohistochemistry.Results. MDK expression was increased in NSCLC tissues compared with paired normal lung tissues in microarray data (GSE19804). MDK mRNA and protein expression were obviously increased in NSCLC tissues than in paired adjacent normal lung tissues. Using immunohistochemistry, MDK protein overexpression was positively correlated with status of clinical stage, T classification, N classification, and M classification in NSCLC patients. In survival analysis, patients with higher MDK protein expression had a significantly shorter overall survival time than did patients with lower MDK protein expression. Multivariate analysis indicated that the MDK protein overexpression was an independent poor prognostic indicator for patients with NSCLC.Conclusions. MDK plays an important role in NSCLC progression and prognosis and may act as a convincing prognostic indicator for NSCLC patients. (C) 2015 IMSS. Published by Elsevier Inc.

Transiently Truncated and Differentially Regulated Expression of Midkine During Mouse Embryogenesis

Promotion of Self-Renewal of Embryonic Stem Cells by Midkine

Abnormal expression, highly efficient detection and novel truncations of midkine in human tumors, cancers and cell lines.

Midkine in Tumorigenesis and Tissue Regeneration

Expression of Midkine in Ameloblastomas and Its Correlation with Clinicopathologic Parameters.

MDK Protein Overexpression Correlates with the Malignant Status and Prognosis of Non-small Cell Lung Cancer

Multiple pathophysiological roles of midkine in human disease

Over-expressed and Truncated Midkines Promote Proliferation of BGC823 Cells in Vitro and Tumor Growth in Vivo.

Increased Proliferation Of Human Gastricarcinoma Cell Line Bgc823 Transfected With Midkine And Truncated Midkine Gene

Midkine Induces Epithelial-Mesenchymal Transition Through Notch2/Jak2-Stat3 Signaling in Human Keratinocytes

High Expression of Midkine (MK) Indicates Poor Prognosis in Childhood Acute Lymphoblastic Leukemia.

Cloning and Expression of Truncated Midkine Cytokine from Gastric Carcinogenesis Tissue in E. Coli

Clinical Significance of MK Expression in Gastric Carcinoma

[Expression of Midkine Fusion Protein and Preparation and Application of Its Monoclonal Antibodies].

Overexpression of Midkine Promotes the Viability of BA/F3 Cells.

Increased Midkine and Estrogen Receptor-Β Expression in Human Non-Small Cell Lung Cancer

Differential Expression of Midkine Mrna in Human Oesophagus Cancer Tissue

Functional Receptors and Intracellular Signal Pathways of Midkine (MK) and Pleiotrophin (PTN)

Characterization of Microrna Expression Profiles and the Discovery of Novel Micrornas Involved in Cancer During Human Embryonic Development.

Midkine Promotes Tetraspanin-Integrin Interaction and Induces Fak-Stat1 Alpha Pathway Contributing to Migration/Invasiveness of Human Head and Neck Squamous Cell Carcinoma Cells

Expression and Significance of Midkine Protein in Non-small-cell-lung Carcinoma